Guillou, Hervé

The gut microbiota: a major player in the toxicity of environmental pollutants?

Claus, S. P., Guillou, H., & Ellero-Simatos, S. (2016) · npj Biofilms and Microbiomes

Gut microbiota and healthMicrobial bioremediation and biosurfactants

Cited by 678

The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans

Benhamed, F., Denechaud, P.-D., Lemoine, M., Robichon, C., Moldes, M., Bertrand-Michel, J., Ratziu, V., Serfaty, L., Housset, C., Capeau, J., et al. (2012) · Journal of Clinical Investigation

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and Disease

Cited by 408

ELOVL2 controls the level of n-6 28:5 and 30:5 fatty acids in testis, a prerequisite for male fertility and sperm maturation in mice

Zadravec, D., Tvrdik, P., Guillou, H., Haslam, R., Kobayashi, T., Napier, J. A., Capecchi, M. R., & Jacobsson, A. (2011) · Journal of Lipid Research

Sperm and Testicular FunctionFatty Acid Research and Health

Cited by 146

Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals

Montagner, A., Korecka, A., Polizzi, A., Lippi, Y., Blum, Y., Canlet, C., Tremblay-Franco, M., Gautier-Stein, A., Burcelin, R., Yen, Y.-C., et al. (2016) · Scientific Reports

Circadian rhythm and melatoninGut microbiota and health

Cited by 137

A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response

Iroz, A., Montagner, A., Benhamed, F., Levavasseur, F., Polizzi, A., Anthony, E., Régnier, M., Fouché, E., Lukowicz, C., Cauzac, M., et al. (2017) · Cell Reports

Fibroblast Growth Factor ResearchPeroxisome Proliferator-Activated Receptors

Cited by 128

Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver

Habib, A., Chokr, D., Wan, J., Hegde, P., Mabire, M., Siebert, M., Ribeiro-Parenti, L., Le Gall, M., Lettéron, P., Pilard, N., et al. (2019) · Gut

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 91

GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation

Kostadinova, R., Montagner, A., Gouranton, E., Fleury, S., Guillou, H., Dombrowicz, D., Desreumaux, P., & Wahli, W. (2012) · Cell & Bioscience

Liver physiology and pathologyPeroxisome Proliferator-Activated Receptors

Cited by 83

GPCR activation of Ras and PI3Kγ in neutrophils depends on PLCβ2/β3 and the RasGEF RasGRP4

Suire, S., Lécureuil, C., Anderson, K. E., Damoulakis, G., Niewczas, I., Davidson, K., Guillou, H., Pan, D., Clark, J., Hawkins, P. T., et al. (2012) · The EMBO Journal

Protein Kinase Regulation and GTPase SignalingPI3K/AKT/mTOR signaling in cancer

Cited by 77

Regulation of hepatokine gene expression in response to fasting and feeding: Influence of PPAR-α and insulin-dependent signalling in hepatocytes

Smati, S., Régnier, M., Fougeray, T., Polizzi, A., Fougerat, A., Lasserre, F., Lukowicz, C., Tramunt, B., Guillaume, M., Burnol, A.-F., et al. (2020) · Diabetes & Metabolism

Peroxisome Proliferator-Activated ReceptorsFibroblast Growth Factor Research

Cited by 47

FGF19 and its analog Aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis

Ursic-Bedoya, J., Desandré, G., Chavey, C., Marie, P., Polizzi, A., Rivière, B., Guillou, H., Assenat, E., Hibner, U., & Gregoire, D. (2024) · EMBO Molecular Medicine

Fibroblast Growth Factor ResearchHepatocellular Carcinoma Treatment and Prognosis

Cited by 11

FGF19 and its analog Aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis

Ursic-Bedoya, J., Desandré, G., Chavey, C., Marie, P., Polizzi, A., Rivière, B., Guillou, H., Assenat, E., Hibner, U., & Gregoire, D. (2023) · EMBO Molecular Medicine

Fibroblast Growth Factor ResearchHepatocellular Carcinoma Treatment and Prognosis

Cited by 11